Search - tctmd.com

Displaying 1 - 10 of 10

Sort: Relevancy | Date

News Conference News CX Symposium 2025

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

L.A. McKeown

April 23, 2025

News Industry News

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

January 21, 2025

News Industry News

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

June 01, 2023

News Industry News

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

May 01, 2023

News Industry News

Concept Medical announces index patient enrolment in world’s first RCT with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease.

September 14, 2020

News Industry News

Enrolment initiated in World’s First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

August 28, 2020

Presentation TCT 2019

The MagicTouch PTA Sirolimus-Coated Balloon: Insights From Preclinical Evaluation

Presenter: Aloke Finn

September 28, 2019

News Industry News

Concept Medical Inc. Granted 'Breakthrough Device Designation' From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon

August 29, 2019

News Industry News

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

August 13, 2019

Partner Content

Future and Scope of Sirolimus-Coated Balloon in Peripheral Vascular Treatment - Concept Medical

November 5, 2019

Advertisement

Paclitaxel or Sirolimus: New PAD Studies Shed Light on Choices

Concept Medical Announces First Patient Enrollment in the MAGICAL BTK IDE Trial, Launching its PAD Clinical Program in the United States

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

Concept Medical received IDE approval to investigate safety and efficacy of its MagicTouch Sirolimus Coated Balloon Catheter for the treatment of small coronary artery disease

Concept Medical announces index patient enrolment in world’s first RCT with Sirolimus Coated Balloon for the treatment of Superficial Femoral Artery (SFA) in Peripheral Artery Disease.

Enrolment initiated in World’s First RCT with Sirolimus Coated Balloon for the treatment of Below-the-Knee (BTK) Peripheral Artery Disease

The MagicTouch PTA Sirolimus-Coated Balloon: Insights From Preclinical Evaluation

Concept Medical Inc. Granted 'Breakthrough Device Designation' From the FDA for Its MagicTouch AVF Sirolimus Coated Balloon

2nd ‘Breakthrough Device Designation’ granted to Concept Medical Inc. by FDA for MagicTouch PTA Sirolimus Coated Balloon

Future and Scope of Sirolimus-Coated Balloon in Peripheral Vascular Treatment - Concept Medical

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content